Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 29.30
+0.55 (1.91%)
At close: Feb 11, 2026
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.07 billion as of February 13, 2026. Its market cap has increased by 21.58% in one year.
Market Cap
1.07B
Enterprise Value
1.44B
Revenue
798.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.30
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.07B, a decrease of -44.82%. That is a compound annual growth rate of -18.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.07B | -5.79% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.81B |
| Tien Liang BioTech | 1.76B |
| InnoPharmax | 1.72B |
| Winston Medical Supply | 1.50B |
| DV Biomed | 1.44B |
| Excelsior Biopharma | 1.23B |
| Mediera | 1.08B |
| Anxo Pharmaceutical | 1.05B |